Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Garrido

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Haematologica|February 9, 2019
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphomaBlanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Julia Salmeron-Villalobos, et al.
Scientific Reports|April 5, 2019
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional studyMaria Rosa López-Huertas, Claudia Palladino, Marta Garrido-Arquero, et al.
The EMBO Journal|September 22, 2023
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapyIrene Pecharromán, Laura Solé, Daniel Álvarez-Villanueva, et al.
Cell Reports|June 22, 2022
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokinesDavid Corujo, Roberto Malinverni, Juan Carrillo-Reixach, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Nature Communications|February 3, 2025
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testingAlice Perucca, Andrea Gómez Llonín, Oriol Mañé Benach, et al.
Gut|April 14, 2026
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapyMar Iglesias Coma, Jordi Badia-Ramentol, Carolina Martinez-Ciarpaglini, et al.
Pediatric Blood & Cancer|August 24, 2022
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphomaJulia Salmerón-Villalobos, Joan Enric Ramis-Zaldivar, Olga Balagué, et al.
Nature Communications|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosisLaura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, et al.
Nature Communications|February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapyJenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Haematologica|February 9, 2019
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphomaBlanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Julia Salmeron-Villalobos, et al.
Scientific Reports|April 5, 2019
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional studyMaria Rosa López-Huertas, Claudia Palladino, Marta Garrido-Arquero, et al.
The EMBO Journal|September 22, 2023
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapyIrene Pecharromán, Laura Solé, Daniel Álvarez-Villanueva, et al.
Cell Reports|June 22, 2022
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokinesDavid Corujo, Roberto Malinverni, Juan Carrillo-Reixach, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Nature Communications|February 3, 2025
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testingAlice Perucca, Andrea Gómez Llonín, Oriol Mañé Benach, et al.
Gut|April 14, 2026
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapyMar Iglesias Coma, Jordi Badia-Ramentol, Carolina Martinez-Ciarpaglini, et al.
Pediatric Blood & Cancer|August 24, 2022
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphomaJulia Salmerón-Villalobos, Joan Enric Ramis-Zaldivar, Olga Balagué, et al.
Nature Communications|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosisLaura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, et al.
Nature Communications|February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapyJenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Pageof 9